Ginkgolide A - CAS 15291-75-5
Catalog number: 15291-75-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
GABA Receptor
Ginkgolide A is an extract from in Ginkgo biloba and a g-aminobutyric acid (GABA) antagonist with a Ki of 14.5 μM.
Ginkgolide A; BN 52020; BN 52020; BN-52020;
Canonical SMILES:
1. Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
Tomohiro Nabekura • Takeshi Yamaki • Kazuyuki Ueno • Shuji Kitagawa. Cancer Chemother Pharmacol (2008) 62:867–873
The ingredients of sesame, ginkgo, and soybean are now widely used in commercially available dietary supplements. Sesamin, a lignan existing exclusively and abundantly in sesame (Sesamum indicum) seeds, is thought to have antioxidative activity and hypocholesteromic eVects. Sesamin is a common ingredient of dietary supplements, especially in Japan. Ginkgo (Ginkgo biloba) leaf extracts containing ginkgolide A, B, and C, and bilobalide are reported to provide protection against neural and vascular damage [12]. Ginkgo leaf extracts are available as medical drugs in Europe, and as herbal preparations in other countries. Soybean (Glycine max) products containing isoXavones such as genistein, daidzein and glycitein, and lignan matairesinol are also well consumed as dietary supplements or foods such as tofu and soy sauce. Licorice (Glycyrrhiza glabra) extract containing glycyrrhizin, glycyrrhetinic acid, glabridin, liquiritigenin, and isoliquiritigenin is one of the major components of traditional Chinese medicine . Licorice extracts are also widely used as sweetening agents for foods such as soy sauce and licorice candy. Phyllodulcin from Amacha (Hydrangea macrophylla var. thunbergii), and stevioside, steviol, and isosteviol from Stevia (Stevia rebaudiana) are used as food sweeteners.
2. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract(EGb 761) during ischemia and reperfusion
Thibaut Liebgott, Malvina Miollan, Yves Berchadsky, Katy Drieu, Marcel Culcasi, Sylvia Pietri. Basic Res Cardiol 95: 368 – 377 (2000)
With further regard to this cardioprotective role of the terpenoid constituents of EGb 761, a series of studies conducted with hypoxic cultured endothelial cells treated with bilobalide, with ischemic-reperfused isolated hearts, or with heart mitochondrial preparations from rats that had been pretreated orally with ginkgolide A or bilobalide have recently indicated they might act at the membrane and/or at the mitochondrial levels during the pre-ischemic period. This hypothesis is in accord with the present observation that the ventricular contracture that occurred during ischemia was significantly suppressed in hearts that were exposed to ginkgolides or to a low concentration of EGb 761, as compared to untreated hearts (Table 1). Although an in vitro O2•–scavenging activity of the terpenoid constituents of EGb 761 (except for ginkgolide A) in a lipophilic environment has been recently reported, the published second-order rate constants are relatively modest. Hence, direct O2•–-trapping within the membrane of the ischemic-reperfused heart does not seem to be a relevant mechanism for explaining their cardio-protective action.
3. Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: Antagonizing effect of ginkgolides and bilobalide
Connie W.H. Woo, Filly Cheung, Vincent W.H. Chan, Yaw L. Siow and Karmin O. Molecular and Cellular Biochemistry 243: 37–47, 2003
Next, we investigated the effect of EGb and its terpenoids on homocysteine-induced iNOS expression in macrophages. As shown in Fig. 3A, EGb at the concentration of 100 µg/mL or ginkgolide A, ginkgolide B and bilobalide at the concentration of 0.5 µg/mL completely abolished homocysteine-stimulated iNOS activation. Further analysis revealed that EGb, ginkgolide A, ginkgolide B or bilobalide treatment also blocked homocysteine-induced iNOS protein and iNOS mRNA expression in macrophages (Figs 3B and 3C). Addition of SOD (300 units/mL) to the culture medium also completely abolished homocysteine-stimulated iNOS activity and expression (Fig. 3).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related GABA Receptor Products

CAS 62666-20-0 Progabide

(CAS: 62666-20-0)

Progabide is a gamma-aminobutyric acid (GABA) antagonist. It has agonistic activity for both the GABAA and GABAB receptors. It has antiepileptic activity and is...

CAS 160296-13-9 SB 205384

SB 205384
(CAS: 160296-13-9)

SB 205384 is a GABAA receptor modulator. SB 205384 potentiates α6, α3 and α5-subunit-containing receptors (EC50 = 280, 695 and 730 nM, respectively). It exhibit...

CAS 64-65-3 Bemegride

(CAS: 64-65-3)

Bemegride is a central nervous system stimulant and antidote for barbiturate poisoning.

CAS 188116-07-6 AWD 131-138

AWD 131-138
(CAS: 188116-07-6)

AWD 131-138 is a partial agonist of GABAA receptor with low affinity for the benzodiazepine binding site. AWD 131-138 exhibits potent anticonvulsant and anxioly...

CAS 111205-55-1 CGS 20625

CGS 20625
(CAS: 111205-55-1)

CGS 20625 is a partial agonist for the benzodiazepine binding site of the GABAA receptor used as an anti-anxiety drug. It acts as a central benzodiazepine recep...

CAS 1216574-52-5 ZK 93423 hydrochloride

ZK 93423 hydrochloride
(CAS: 1216574-52-5)

ZK 93423 hydrochloride is a potent and non-selective benzodiazepine receptor agonist (IC50 = 1 nM) (Ki = 4.1, 4.2, 6 and 4.5 nM for inhibition of [3H]Ro15-1788 ...

CAS 252977-51-8 TPA023

(CAS: 252977-51-8)

TPA023, also called as MK-0777, is a subtype-selective, mixed agonist-antagonist at GABAA receptor with anxiolytic and anticonvulsant effects.

CAS 85118-33-8 THIP hydrochloride

THIP hydrochloride
(CAS: 85118-33-8)

THIP hydrochloride is a GABAA receptor agonist and GABAA-ρ receptor antagonist. THIP exhibits antinociceptive, anticonvulsant and sedative effects. It is used a...

Chemical Structure

CAS 15291-75-5 Ginkgolide A

Quick Inquiry

Verification code

Featured Items